Pleural effusions complicate up to 57% of bacterial pneumonias. They vary in severity, ranging from uncomplicated effusions to empyema. Some require only antibiotics and observation, while others ...
AUSTIN, Texas--(BUSINESS WIRE)--Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the closing of $36 ...
TOKYO & AUSTIN, Texas--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd, (“Taiho”) and Lung Therapeutics, Inc. (“Lung Tx”) announced today an exclusive license agreement of LTI-01, a recombinant human ...
Malignant pleural effusion (MPE) affects up to 15% of patients with cancer, and its incidence and prevalence are increasing. 1 - 4 Most cases are symptomatic; the most common symptoms are dyspnea due ...
Empyema is considered to be a sub-classification of parapneumonic pleural effusion. A parapneumonic effusion describes the build-up of activated pleural fluid which is associated with a lung infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results